Norway· NO-ID_DC8CE2D3-19C2-4B65-91E6-C6AC7CEBD12C
Tepmetko
A tepotinib product containing tepotinib, registered in Norway by Merck Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tepotinib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EP02 (tepotinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Tepotinib · ATC L01EP02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tepotinib costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tepotinib · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$259.05
The record
At a glance
FEST (Norway)- Active substance
- Tepotinib
- Manufacturer
- Merck Europe B.V.
- Country
- Norway (NO)
- ATC code
- L01EP02
- ATC class
- Tepotinib
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DC8CE2D3-19C2-4B65-91E6-C6AC7CEBD12C
- no_varenummer17638760NOK 107948.2
- gtin4065267789583
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tepotinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTEPMETKOAbacus Medicine A/S
- SwitzerlandTepmetko 225 mg, FilmtablettenMerck (Schweiz) AG
- CzechiaTEPMETKOMerck Europe B.V., Amsterdam
- SpainTEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Europe B.V.
- IrelandTEPMETKO 225 mg film-coated tabletsMerck Europe B.V.
- IcelandTEPMETKOMerck Europe B.V.*
- NetherlandsTepmetko 225 mg, filmomhulde tablettenMerck Europe B.V.
- PolandTepmetkoMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Tepmetko
- Liechtenstein · Tepmetko
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce460fa9-e8f3-44e0-9423-72317384fdd4 GET /v1/drugs/ce460fa9-e8f3-44e0-9423-72317384fdd4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Tepotinib",
"merkevare_id": "ID_DC8CE2D3-19C2-4B65-91E6-C6AC7CEBD12C",
"name_form_strength": "Tepmetko tab 225 mg",
"prescription_group": "C"
}See everything about tepotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.